TRIED AND TRUSTED FOR MORE THAN 35 YEARS
It is hard to believe that the first Medtronic insulin pump was launched 35 years ago.
Through the years Medtronic MiniMed™ has evolved from a basic insulin pump - to the Paradigm insulin pump that can monitor your glucose levels - to the MiniMed™ 640G with SmartGuard™ technology.
Our technologies have supported over 1.2 million people living with diabetes around the world.
Our latest MiniMed™ 640G pump system has pushed the boundaries and we are very proud of its tried and trusted automatic insulin suspend technology
With more than 280 000 days of patient data on the MiniMed™ 640G with SmartGuard™ technology showed that patients spent 64% of the time in range (3.9mmol/L – 10mmol/L).1
MiniMed™ 640G reduced low blood sugar’s, thanks to SmartGuard™ technology. SmartGuard Suspend Before Low technology can reduce the frequency of lows and help stabilise your glucose levels after insulin delivery is restarted. A study done of SmartGuard technology showed that 76.8% of low limits, set on the pump, were avoided through the use of SmartGuard™ 2
Our new CarelinkTM Personal software, now allows you to upload your insulin pump, without the use for Java.
CarelinkTM Personal software’s unique functionality allows your healthcare professional to see your pump data from their practice computer. If your clinic has the CareLink™ Pro software you can give them permission to access your account. This allows them to link from their computer to your online account and pull your uploaded data into their records, quickly and securely.
Our patients inspire us everyday to keeping improving our technologies so that they can live the best life they can live. The MiniMed™ 640G system represents a further advancement in automation and continues to lay the groundwork for our Hybrid Closed Loop and Personalised Closed Loop.
Posted by: Ronel Hentschel
1. Zhong A. et al. Effectiveness of Automated Insulin Management Features of the Medtronic 640G Sensor-Augmented Insulin Pump. Diabetes Technol Ther. 2016; 18(10): 657-663.
2. Biester T. et al. ‘‘Let the Algorithm Do the Work’’: Reduction of Hypoglycemia Using Sensor-Augmented Pump Therapy with Predictive Insulin Suspension (SmartGuard) in Pediatric Type 1 Diabetes Patients. Diabetes Technol Ther. 2017;19(3):173-182.